Molecular genetic analysis of malignant ovarian germ cell tumors

被引:15
|
作者
Faulkner, SW
Friedlander, ML
机构
[1] Prince Wales Hosp, Dept Med Oncol, Randwick, NSW 2031, Australia
[2] Prince Wales Hosp, SEALS, Dept Haematol, Mol & Cytogenet Unit, Randwick, NSW 2031, Australia
关键词
D O I
10.1006/gyno.2000.5762
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Relatively little is known about the molecular mechanisms involved in the initiation and progression of ovarian germ cell tumors (OGCTs), in contrast to testicular germ cell tumors (TGCTs) which have been extensively investigated, Ovarian germ cell tumors share many pathological and biological features with TGCTs and it is likely that they share similar molecular genetic alterations, although this has not been studied in detail, The aim of this study was to compare and contrast loss of heterozygosity (LOH) in OGCTs at chromosomal regions that are commonly involved in TGCTs. Methods. Universal amplification was performed on 35 paired specimens of malignant OGCT and constitutional DNA that had been microdissected from single paraffin-embedded tissue sections in 32 patients. Sixty-two microsatellite markers were used to assess LOH at chromosomal regions mapping to 3q, 5q, 9p, 11p, 11q, 12q, 17p, and 18q as these are commonly involved in testicular germ cell tumors. Results. Assessment of these regions demonstrated common sites of deletion at 3q27-q28 (50%), 5q31 (33%), 5q34-q35 (46%), 9p22-p21 (32%) and 12q22 (53%) in all histological subtypes of OGCT, We and others have previously found these regions to be frequently deleted at early stages of tumor development in TGCTs, Conclusions. These chromosomal regions may contain tumor suppressor genes that are important in the initiation and progression of both malignant OGCTs and TGCTs. (C) 2000 Academic Press.
引用
收藏
页码:283 / 288
页数:6
相关论文
共 50 条
  • [21] TREATMENT OF OVARIAN MALIGNANT GERM CELL TUMORS WITH PRESERVATION OF FERTILITY
    龙菱
    姜萍
    刘芬哲
    王香平
    赵同健
    CHINESEMEDICALJOURNAL, 1993, (04)
  • [22] TRENDS IN THE SURGICAL MANAGEMENT OF MALIGNANT OVARIAN GERM CELL TUMORS
    Nasioudis, D.
    Mastroyannis, S.
    Haggerty, A.
    Giuntoli, R., II
    Burger, R.
    Morgan, M.
    Ko, E.
    Latif, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 915 - 915
  • [23] Treatment of recurrent and persistent malignant ovarian germ cell tumors
    王含必
    杨佳欣
    沈铿
    郎景和
    生殖医学杂志, 2009, 18(S2) (S2) : 64 - 68
  • [24] Malignant ovarian germ cell tumors: the KK Hospital Experience
    Khi, C
    Low, JJH
    Tay, EH
    Chew, SH
    Ho, TH
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2002, 23 (03) : 251 - 256
  • [25] Genetic analysis of ovarian germ cell tumors by comparative genomic hybridization (CGH).
    Riopel, MA
    Perlman, EJ
    LABORATORY INVESTIGATION, 1997, 76 (01) : 627 - 627
  • [26] Molecular Characteristics of Malignant Ovarian Germ Cell Tumors and Comparison With Testicular Counterparts: Implications for Pathogenesis
    Kraggerud, Sigrid Marie
    Hoei-Hansen, Christina E.
    Alagaratnam, Sharmini
    Skotheim, Rolf I.
    Abeler, Vera M.
    Rajpert-De Meyts, Ewa
    Lothe, Ragnhild A.
    ENDOCRINE REVIEWS, 2013, 34 (03) : 339 - 376
  • [27] MALIGNANT GERM CELL TUMORS - OUTCOME ANALYSIS
    Sarin, Yogesh
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 784 - 784
  • [28] MALIGNANT GERM CELL TUMORS - OUTCOME ANALYSIS
    Sarin, Yogesh Kumar
    Sinha, S.
    Goswami, R. N. G.
    Raghunath, B. V.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 733 - 733
  • [29] Malignant ovarian germ cell tumors: A retrospective analysis of the Russian Cancer Research Center
    Streltsova, O.
    Fedjanin, M.
    Bulanov, A.
    Zhordania, K.
    Kuznetsov, V.
    Tjulandin, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] A retrospective analysis of the pattern of care and survival in patients with malignant ovarian germ cell tumors
    Agarwal, Reshu
    Rajanbabu, Anupama
    Keechilattu, Pavithran
    Nair, Indu R.
    Vijaykumar, D. K.
    Unnikrishnan, U. G.
    SOUTH ASIAN JOURNAL OF CANCER, 2019, 8 (01) : 35 - +